[Computational-biology] Structure-Based Drug Design

[Jim Prudhomme]

***Registration is Now Open for Cambridge Healthtech Institute’s
Conference***

Structure-Based Drug Design: Sophisticated Approaches to Drug Discovery
June 4-5, 2009
Royal Sonesta Hotel, Cambridge, Massachusetts
www.healthtech.com/SBD/overview.aspx

 

Topics of discussion include:

-          Target Structure-Guided Drug Discovery

-          Feeding SBDD with Biochemical and Biophysical Information

-          Ligand-Based Predictions Applied to Drug Design

-          SBDD and Computational Chemistry Methods: A Marriage of
Innovation

-           SBDD of Pharmacological Chaperons


Distinguished Faculty:

Alex Aronov, Ph.D., Vertex Pharmaceuticals, Inc.

 

Xavier Barril, Ph.D. , ICREA Research Universitat de Barcelona

 

Alex Burgin, Ph.D., deCODE Biostructures

 

Miles Congreve, Ph.D., Heptares Therapeutics Ltd.

 

José Duca, Ph.D., Schering Plough Research Institute

 

Stefan Geschwindner, Ph.D., AstraZeneca R&D Mölndal

 

Ajay N. Jain, Ph.D., University of California, San Francisco

 

Paul Labute, Ph.D., Computing Group (CCG)

 

Dr. Richard J. Law, Evotec AG

 

Brian B. Masek, Ph.D., Tripos International

 

Mark Murcko, Ph.D., Vertex Pharmaceuticals, Inc.

 

Sander Nabuurs, Ph.D., Radboud University Nijmegen

 

Enrico O. Purisima, Ph.D., National Research Council of Canada

 

Dagmar Ringe, Ph.D., Brandeis University

 

Suo-Bao Rong, Ph.D., Pfizer Global R&D

 

Tomi Sawyer, Ph.D., AILERON Therapeutics; Editor-in-Chief, Chemical Biology
& Drug Design

 

Andrew D. Scott, Ph.D., Pfizer Global Research and Development

 

Suresh Singh, Ph.D., Vitae Pharmaceuticals

 

Raymond C. Stevens, Scripps Research Institute

 

Gergely Toth, Ph.D., Elan Pharmaceuticals

 

Marcel Verdonk, Ph.D., Astex Therapeutics, Ltd.

 

Markus Wagener, Ph.D., Schering-Plough Research Institute

 

W. Patrick Walters, Ph.D., Vertex Pharmaceuticals, Inc.

 

Plus! Pre-Conference Workshop, Wednesday, June 3

Designing Kinase Inhibitors*

 

Topics Discussed:

- Challenges of Crystal Structures

- X-Ray Crystallography

- Target Immobilized NMR Screening

*Separate registration is required.

 

Arrive early to attend...

Protein Kinase Targets

June 1-3

www.healthtech.com/KIN/overview.aspx

 

Interested in Sponsorships and Exhibit Opportunities?

Contact:

Katelin Fitzgerald

Manager, Business Development

Tel: 781-972-5458

E-mail: kfitzgerald from healthtech.com

 

Special Pricing is Available to Attend Both the Structure-Based Drug Design
and Protein Kinase Conferences.

Learn more and register at www.healthtech.com/SBD/overview.aspx

Otherwise, call CHI at 781-972-5400.